Thyroid dysfunction and insulin resistance in end-stage renal disease patients before and 1 year after starting maintenance hemodialysis: A prospective multicenter study

Semin Dial. 2022 Mar;35(2):138-145. doi: 10.1111/sdi.13044. Epub 2021 Dec 8.

Abstract

Background: Thyroid dysfunction and insulin resistance (IR) are common findings in patients with ESRD. We aimed to evaluate thyroid dysfunction and IR in ESRD before and after 1 year of starting hemodialysis (HD).

Methods: This was a prospective study that recruited newly starting HD patients who fulfilled the inclusion criteria. Patients were evaluated for TSH, free T4, free T3, fasting insulin, fasting glucose, HOMA-IR, serum ferritin, and hs-CRP levels before starting their first dialysis session and after 1 year of regular HD.

Results: Eighty-one patients have completed the 1-year follow-up period. After 1 year of regular HD, there were statistically significant increments of hs-CRP, serum ferritin, and TSH levels. On the other hand, fasting insulin level and HOMA-IR showed statistically significant increments after 1 year of starting HD. After 1 year of regular HD, TSH level showed a positive correlation with hs-CRP and serum ferritin level, while free T3 was negatively correlated with HOMA-IR. On the other hand, there was a significant positive correlation between HOMA-IR, hs-CRP, and serum ferritin levels, while HOMA-IR was negatively correlated with Kt/V.

Conclusions: This study suggests overlapping complex pathogenesis of thyroid dysfunction, chronic inflammation, and IR in chronic HD patients.

Publication types

  • Multicenter Study

MeSH terms

  • C-Reactive Protein / analysis
  • Female
  • Ferritins
  • Humans
  • Insulin
  • Insulin Resistance*
  • Kidney Failure, Chronic* / therapy
  • Male
  • Prospective Studies
  • Renal Dialysis / adverse effects
  • Thyroid Gland / chemistry
  • Thyrotropin

Substances

  • Insulin
  • Thyrotropin
  • C-Reactive Protein
  • Ferritins